Broadfin Capital’s ICU Medical ICUI Stock Holding History

Broadfin Capital’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$5.61M	Hold	30,000	–	–	0.75%	31
2019 Q3	$4.79M	Buy	+30,000	New	+$5.97M	0.89%	29

Other funds holding ICUI

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nitorum Capital New York $114M AUM 17.21% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

FPP

Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return

Broadfin Capital's ICUI Position: Q4 2019 in Review

Broadfin Capital held its ICU Medical (ICUI) position steady in Q4 2019 at 30,000 shares worth $5.61M. The position accounts for 0.75% of the portfolio, ranked #31.

Broadfin Capital first reported a position in ICUI in Q3 2019 and has held it in 2 quarters since. 267 funds tracked by Wall St. Rank hold ICUI as of Q4 2019.

Broadfin Capital held 30,000 shares of ICU Medical worth $5.61M as of Q4 2019.
Broadfin Capital left its ICU Medical share count unchanged in Q4 2019.
ICU Medical made up 0.75% of Broadfin Capital's portfolio in Q4 2019, its #31 holding.
Broadfin Capital first reported a position in ICU Medical in Q3 2019 and has held it in 2 quarters since.
267 funds tracked by Wall St. Rank held ICU Medical as of Q4 2019.

Based on Broadfin Capital's 13F filing for Q4 2019, filed 14 Feb 2020.